U.S. Markets closed

The Blackstone Group L.P. (BX)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
34.55+0.20 (+0.58%)
At close: 4:01PM EDT

34.55 0.00 (0.00%)
After hours: 6:16PM EDT

People also watch
KKRMSGSBLKFIG
Full screen
Previous Close34.35
Open34.56
Bid34.55 x 900
Ask34.65 x 100
Day's Range34.43 - 34.80
52 Week Range23.33 - 35.09
Volume3,567,714
Avg. Volume4,775,398
Market Cap42.14B
Beta1.23
PE Ratio (TTM)17.06
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.48 (10.11%)
Ex-Dividend Date2017-04-27
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com2 hours ago

    Blackstone: Innovation Could Lead to More Upside

    Blackstone Group's (BX) stock has risen nearly 30% to a recent $34.58 so far this year, but one analyst thinks the company's shares have even more room to run. Morgan Stanley analyst Michael Cyprys, who has an Overweight rating on Blackstone stock, raised his price target by $3 to $40, implying upside of 17%. The analyst thinks that Blackstone deserves an Overweight rating because it offers the best mix of products to drive cash earnings higher, has a fundraising machine that is expected to raise $100 billion this year and in 2018, and is best-positioned among alternative asset management firms with a leading position across major categories.

  • Moody's6 hours ago

    APX Group, Inc. -- Moody's downgrades Vivint's CFR to B3, unsecured debt to Caa2; assigns Caa2 ratings to new unsecured debt

    Rating Action: Moody's downgrades Vivint's CFR to B3, unsecured debt to Caa2; assigns Caa2 ratings to new unsecured debt. Global Credit Research- 25 Jul 2017. Approximately $2.8 billion of rated debt affected....

  • Reuters13 hours ago

    China's HNA taps Goldman for planned Pactera U.S. IPO - sources

    HNA Group, the Chinese airline-to-banking conglomerate, has tapped investment bank Goldman Sachs to list Pactera, the Beijing-based IT outsourcing firm it bought from private equity firm Blackstone, sources familiar with the matter said. The mandate for the U.S. initial public offering of Pactera, bought for $675 million in cash last year, is not yet official, the sources said, but the listing could come early next year.